Equities researchers at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a note issued to investors on Thursday. The brokerage set a “sell” rating on the stock.
Ampio Pharmaceuticals Trading Up 8.7 %
Shares of NYSE:AMPE opened at $0.25 on Thursday. The stock has a market capitalization of $285,000.00, a PE ratio of -0.02 and a beta of 2.14. The firm has a 50 day moving average of $0.60 and a 200-day moving average of $1.53. Ampio Pharmaceuticals has a 12 month low of $0.14 and a 12 month high of $8.30.
Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) last released its earnings results on Wednesday, March 27th. The company reported ($2.48) earnings per share for the quarter.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
See Also
- Five stocks we like better than Ampio Pharmaceuticals
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- NASDAQ 100 vs. NASDAQ Composite: A Detailed Breakdown of NASDAQ
- Investing In Automotive Stocks
- These 2 Retail Traders Favorites are Nearing Major Breakouts
- Find and Profitably Trade Stocks at 52-Week Lows
- Snowflake is Melting… Up, With a Double-Digit Upside Potential
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
